CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $88,000 | +57.1% | 44,766 | +0.3% | 0.00% | – |
| Q4 2020 | $56,000 | -30.0% | 44,648 | -0.0% | 0.00% | – |
| Q3 2020 | $80,000 | -76.5% | 44,659 | +10.2% | 0.00% | -100.0% |
| Q2 2020 | $340,000 | +66.7% | 40,520 | +4.0% | 0.00% | +100.0% |
| Q1 2020 | $204,000 | +0.5% | 38,974 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $203,000 | +10.9% | 37,171 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $183,000 | -30.2% | 37,482 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $262,000 | +8.3% | 37,744 | +8.2% | 0.00% | 0.0% |
| Q1 2019 | $242,000 | +26.0% | 34,869 | +6.2% | 0.00% | 0.0% |
| Q4 2018 | $192,000 | -23.2% | 32,841 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $250,000 | +52.4% | 33,093 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $164,000 | -14.6% | 32,497 | +3.5% | 0.00% | 0.0% |
| Q1 2018 | $192,000 | -17.2% | 31,396 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $232,000 | +9.4% | 32,650 | +10.0% | 0.00% | 0.0% |
| Q3 2017 | $212,000 | +22.5% | 29,694 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $173,000 | – | 27,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |